Evercore ISI Group initiates coverage of Trex Bio at Outperform, sets price target at $28

What happened

Evercore ISI Group began covering Trex Bio with an Outperform rating and a $28 price target. That target implies a 105.3% gain from the November 2 closing price of $13.64.

Confirmed

Global impact / market context

A new Outperform rating with a target well above the current price signals that one analyst expects strong gains. Other recent targets range from $20 to $39, so buyers may see room for the stock to rise if those views hold.

Analyst inference

Several firms started covering Trex Bio within days of each other, which often happens after a company becomes newly public or gains attention. Their targets span $20 to $39 versus a $13.64 close, so the range shows how much analysts disagree.

Analyst inference

What to watch

1. Evercore ISI Group set a price target of $28, which implies a 105.3% gain from the November 2 close of $13.64. Confirmed
2. Watch whether other analysts change their ratings or price targets after Evercore's new Outperform rating, since targets currently range from $20 to $39. Proposed
3. Track Trex Bio's future updates to see if the company's results move analyst targets toward the low or high end of the current $20 to $39 range. Analyst inference

Evidence

• Original source link unavailable